Roflumilast for psoriasis in skin folds or on genitals
Treatments studied
Part of Skin clinical trials.
This trial tests whether roflumilast cream can effectively treat psoriasis in skin folds or on the genitals for people who have not had success with other creams. If you have this type of psoriasis and other treatments haven't cleared it up, this study might be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have psoriasis in skin folds or on the genitals that has not cleared up after using topical treatments for 4 to 6 weeks.
- You have not taken any systemic psoriasis medication in the last 3 months.
- You have not used any topical treatments for your psoriasis in the last 2 weeks before starting the study.
- You are not pregnant or breastfeeding, and if you are a woman of childbearing age, you agree to use contraception.
- You do not have major health conditions like heart, lung, kidney, liver, or stomach disease, or severe blood disorders.
- You do not have erythrodermic or pustular psoriasis, or psoriatic arthritis.
- You do not have other autoimmune diseases like lupus.
- You do not have a history of cancer such as breast cancer or leukemia.
- You have not received biologic therapy in the last 6 months.
- You are not allergic to roflumilast or methotrexate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medicine called roflumilast for adults with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective when taken by mouth, and you can join if you have not used other systemic treatments recently.
This study tests a new prescription cream called roflumilast to see if it helps with both skin plaques and nail psoriasis. If you join, you'll apply the cream to affected areas and be monitored to see how well it works and if it's safe.
This study tests whether adding roflumilast, a new medication, to your current rheumatoid arthritis treatment can help reduce joint inflammation and improve your symptoms. You would take it alongside methotrexate, a common RA medication you may already be using.
This study tests an oral medicine called roflumilast to see if it helps treat moderate to severe eczema in people aged 12 and up who haven't used other systemic treatments recently. It's a pilot study to check both safety and how well it works.
This trial tests a medicated foam (roflumilast) to relieve skin problems like rash, itching, or eczema that can happen during immune checkpoint inhibitor cancer treatment. The goal is to see if the foam helps clear the skin without needing steroid creams or pills.
This study tests a new foam (roflumilast) applied to the skin to treat seborrheic dermatitis, a condition causing red, flaky patches usually on the scalp or face. It aims to see if the foam reduces redness and scaling better than a placebo.
Hear when a new Flexural Psoriasis (Also Known as Inverse or Intertriginous Psoriasis) and Genital Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.